azomycin has been researched along with Clerambault Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kogelnik, HD | 1 |
| Jentzsch, K; Kärcher, KH; Kogelnik, HD; Maida, E; Mamoli, B; Meyer, JH; Szepesi, T; Wessely, P; Zaunbauer, F | 1 |
1 trial(s) available for azomycin and Clerambault Syndrome
| Article | Year |
|---|---|
Clinical experience with misonidazole: high dose fractions versus daily low doses.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Eruptions; Epilepsy; Female; Hearing Loss; Humans; Male; Middle Aged; Misonidazole; Neurocognitive Disorders; Nitroimidazoles; Peripheral Nervous System Diseases | 1980 |
1 other study(ies) available for azomycin and Clerambault Syndrome
| Article | Year |
|---|---|
Further clinical experiences of a phase I study with the hypoxic cell radiosensitizer misonidazole.
Topics: Adolescent; Adult; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Neurocognitive Disorders; Nitroimidazoles; Peripheral Nervous System Diseases; Radiation-Sensitizing Agents | 1978 |